The mutation profile of EGFR in resectable Chinese lung cancer patients.

e20519Background: The frequency of EGFR mutation in Asian advanced lung cancer patients is about 40% and the application of EGFR tyrosine kinase inhibitors (TKIs) has become a standard treatment th...